Immobilization of insulin-like growth factor-1 onto thermosensitive hydrogels to enhance cardiac progenitor cell survival and differentiation under ischemic conditions

Science China Chemistry

Volumn 57, Issue 4, 2014, Pages 568-578

  Li, Zhenqing ^a   Xu, Yanyi ^a   Li, Haichang ^b   Guan, Jianjun ^a  

^a The Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

cardiac differentiation; cardiosphere derived cells; myocardial infarction; stem cells; thermosensitive hydrogels

Indexed keywords

ACRYLIC MONOMERS; CARBOXYLIC ACIDS; CELL IMMOBILIZATION; CYTOLOGY; ESTERIFICATION; ESTERS; FUNCTIONAL POLYMERS; INSULIN; STEM CELLS;

CARDIAC DIFFERENTIATION; CARDIAC PROGENITORS; INSULIN-LIKE GROWTH FACTOR 1; ISCHEMIC CONDITIONS; MYOCARDIAL INFARCTION; N-ISOPROPYLACRYLAMIDES; STEM CELL THERAPY; THERMO-SENSITIVE HYDROGEL;

HYDROGELS;

EID: 84899464139     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-014-5089-8     Document Type: Article

References (47)

1. Lindoso RS, Araujo DS, Adão-Novaes J, Mariante RM, Verdoorn KS, Fragel-Madeira L, Caruso-Neves C, Linden R, Vieyra A, Einicker-Lamas M. Paracrine interaction between bone marrow-derived stem cells and renal epithelial cells. Cell Physiol Biochem, 2011, 28: 267-278
2. Zuo S, Jones WK, Li H, He Z, Pasha Z, Yang Y, Wang Y, Fan GC, Ashraf M, Xu M. Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev, 2012, 21: 598-608
3. Qian Q, Qian H, Zhang X, Zhu W, Yan Y, Ye S, Peng X, Li W, Xu Z, Sun L, Xu W. 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase. Stem Cells Dev, 2012, 21: 67-75
4. Raynaud CM, Halabi N, Elliott DA, Pasquier J, Elefanty AG, Stanley EG, Rafii A. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PloS One, 2013, 8: e54524
5. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, Speicher DW, Sanger JW, Sanger JM, Discher DE. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci, 2008, 121: 3794-3802
6. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007, 318: 1917-1920
7. He JQ, Vu DM, Hunt G, Chugh A, Bhatnagar A, Bolli R. Human cardiac stem cells isolated from atrial appendages stably express c-kit. PloS One, 2011, 6: e27719
8. Li Z, Guo X, Matsushita S, Guan J. Differentiation of cardiosphere-derived cells into a mature cardiac lineage using biodegradable poly(N-isopropylacrylamide) hydrogels. Biomaterials, 2011, 32: 3220-3232
9. Davis DR, Kizana E, Terrovitis J, Barth AS, Zhang Y, Smith RR, Miake J, Marbán E. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. J Mol Cell Cardiol, 2010, 49: 312-321
10. Wang CC, Chen CH, Lin WW, Hwang SM, Hsieh PCH, Lai PH, Yeh YC, Chang Y, Sung HW. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res, 2008, 77: 515-524
11. Lee S-T, White AJ, Matsushita S, Malliaras K, Steenbergen C, Zhang Y, Li TS, Terrovitis J, Yee K, Simsir S, Makkar R, Marbán E. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol, 2011, 57: 455-465
12. Perin EC, Tian M, Marini FC 3rd, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo Y, Mukhopadhyay, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PloS One, 2011, 6: e22949
13. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg, 2008, 135: 799-808
14. Khan M, Meduru S, Mohan IK, Kuppusamy ML, Wisel S, Kulkarni A, Rivera BK, Hamlin RL, Kuppusamy P. Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol, 2009, 47: 275-287
15. Haider HK, Jiang S, Idris NM, Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res, 2008, 103: 1300-1308
16. Wang F, Li Z, Tamama K, Sen CK, Guan J. Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules, 2009, 10: 2609-2618
17. Li Z, Wang F, Roy S, Sen CK, Guan J. Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. Biomacromolecules, 2009, 10: 3306-3316
18. Li Z, Guo X, Guan J. A Thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions. Biomacromolecules, 2012, 13: 1956-1964
19. Li Z, Guo X, Guan J. An oxygen release system to augment cardiac progenitor cell survival and differentiation under hypoxic condition. Biomaterials, 2012, 33: 5914-5923
20. Enoki C, Otani H, Sato D, Okada T, Hattori R, Imamura H. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int J Cardiol, 2010, 138: 9-18
21. Arsenijevic Y, Weiss S, Schneider B, Aebischer P. Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci, 2001, 21: 7194-7202
22. Pollak A, Blumenfeld H, Wax M, Baughn RL, Whitesides GM. Enzyme immobilization by condensation copolymerization into crosslinked polyacrylamide gels. J Am Chem Soc, 1980, 102: 6324-6336
23. Möller M, Kånge R, Hedrick JL. Sn(OTf)2 and Sc(OTf)3: efficient and versatile catalysts for the controlled polymerization of lactones. J Polym Sci Part A: Polym Chem, 2000, 38: 2067-2074
24. Yuan JS, Reed A, Chen F, Stewart CN. Statistical analysis of real-time PCR data. BMC Bioinformatics, 2006, 7: 85
25. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res, 2011, 108: 792-796
26. Martinez EC, Kofidis T. Adult stem cells for cardiac tissue engineering. J Mol Cell Cardiol, 2011, 50: 312-319
27. Psaltis PJ, Zannettino ACW, Worthley SG, Gronthos S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells (Dayt Ohio), 2008, 26: 2201-2210
28. Habib M, Shapira-Schweitzer K, Caspi O, Gepstein A, Arbel G, Aronson D, Seliktar D, Gepstein L. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials, 2011, 32: 7514-7523
29. Seif-Naraghi SB, Salvatore MA, Schup-Magoffin PJ, Hu DP, Christman KL. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A, 2010, 16: 2017-2027
30. Lee J, Jung S G, Park C S, Kim H Y, Batt CA, Kim YR. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer. Bioorg Med Chem Lett, 2011, 21: 2941-2944
31. Fung Y. Biomechanics: Mechanical Properties of Living Tissues. Springer. 1993
32. Chen Q-Z, Harding SE, Ali NN, Lyon AR, Boccaccini AR. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater Sci Eng R Rep, 2008, 59: 1-37
33. Pohl TLM, Boergermann JH, Schwaerzer GK, Knaus P, Cavalcanti-Adam EA. Surface immobilization of bone morphogenetic protein 2 via a self-assembled monolayer formation induces cell differentiation. Acta Biomater, 2012, 8: 772-780
34. Boucher C, Liberelle B, Jolicoeur M, Durocher Y, De Crescenzo G. Epidermal growth factor tethered through coiled-coil interactions induces cell surface receptor phosphorylation. Bioconjug Chem, 2009, 20: 1569-1577
35. Goyal A, Pal N, Concannon M, Paul M, Doran M, Poluzzi C, Sekiguchi K, Whitelock JM, Neill T, Iozzo RV. Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism. J Biol Chem, 2011, 286: 25947-25962
36. Guan J, Hong Y, Ma Z, Wagner WR. Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability. Biomacromolecules, 2008, 9: 1283-1292
37. Ito Y, Shu QL, Imanishi Y. Enhancement of cell growth on growth factor-immobilized polymer film. Biomaterials, 1991, 12: 449-453
38. Backer MV, Patel V, Jehning BT, Claffey KP, Backer JM. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials, 2006, 27: 5452-5458
39. Miyagi Y, Chiu LLY, Cimini M, Weisel RD, Radisic M, Li RK. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials, 2011, 32: 1280-1290
40. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol, 2005, 46: 1339-1350
41. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J, 2006, 20: 661-669
42. Johnston BM, Mallard EC, Williams CE, Gluckman PD. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs. J Clin Invest, 1996, 97: 300-308
43. Tamatani M, Ogawa S, Tohyama M. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: a possible neuroprotective mechanism of peptide growth factors. Brain Res Mol Brain Res, 1998, 58: 27-39
44. Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh), 1989, 121: 753-758
45. Wang F, Li Z, Khan M, Tamama K, Kuppusamy P, Wagner WR, Sen CK, Guan J. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater, 2010, 6: 1978-1991
46. Florini JR, Ewton DZ, Magri KA, Mangiacapra FJ. IGFs and muscle differentiation. Adv Exp Med Biol, 1993, 343: 319-326
47. Duan C, Ren H, Gao S. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen Comp Endocrinol, 2010, 167: 344-351